Insider Transactions in Q3 2022 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2022
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
255
-0.47%
|
$1,530
$6.92 P/Share
|
|
Sep 19
2022
|
Sheldon L. Koenig President and CEO |
SELL
Open market or private sale
|
Direct |
3,394
-1.68%
|
$20,364
$6.94 P/Share
|
|
Aug 31
2022
|
Eric Warren Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+1.82%
|
$7,000
$7.46 P/Share
|
|
Aug 17
2022
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
199
-0.37%
|
$1,194
$6.82 P/Share
|
|
Aug 05
2022
|
Sheldon L. Koenig President and CEO |
BUY
Open market or private purchase
|
Direct |
8,606
+4.15%
|
$43,030
$5.8 P/Share
|
|
Jul 19
2022
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,901
-3.45%
|
$23,406
$6.55 P/Share
|
|
Jul 19
2022
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
431
-0.8%
|
$2,586
$6.58 P/Share
|